Abstract
Life threatening asthma is a serious condition that is often difficult to treat. Often, despite maximal medical therapies, these patients remain functionally crippled. In addition, older patients are even more susceptible to asthma as they are less able to adapt to or tolerate the symptoms. In this paper we report the effectiveness of a new treatment regimen of high-dose intramuscular triamcinolone (360 mg) in 7 elderly patients with severe, chronic, steroid-dependent asthma. Each patient was given one intramuscular injection of 360 mg of triamcinolone (Kenalog) after maximizing traditional medicines. All 7 patients experienced resolution of their asthma symptoms within 1 week of receiving this injection. They showed marked functional improvement in their activities of daily living, and independence. Six of seven progressed from being homebound to walking, shopping, and grooming without restriction. All had a corresponding rise in peak expiratory flow rates ranging between 25 and 93%. In addition, all were able to stop taking their daily oral prednisone. Response durations ranged from 3 to 24 months. In the 6 patients who experienced relapse, all requested and received a second injection, with similar positive outcomes. Some experienced transient weakness and diabetes during the first week of the therapy but all elected to receive additional shots when they experienced break-through wheezing. Thus, we feel that high-dose intramuscular triamcinolone should be considered as a therapeutic option for a highly select group of older steroid-dependent asthma patients.
Similar content being viewed by others
References
Braman SS, Kaemmerler JT, Davis SM (1991) Asthma in the elderly. Am Rev Resp Dis 143:336–340
Chung KIT (1986) Role of inflammation in the hyperactivity of the airways in asthma. Thorax 41:657–662
Derrick EH (1971) The significance of age of onset of asthma. Med J Aust 1:1317–1319
Ford RM, (1969) Aetiology of asthma: a review of 11,551 cases. Med J Aust 1:628–631
Hurst WJ, Schlant RC, Rackley CE, Sonnenblick EH, Kass Wenger N (eds) (1990) The Heart. McGraw-Hill, New York, pp 627–637
Kaliner M (1984) Hypotheses on the contribution of late-phase allergic responses to the understanding and treatment of allergic diseases. J Allergy Clin Immunol 73:311–315
Macdonald JB, Macdonald ET, Seaton A, Williams DA (1976) Asthma deaths in Cardiff 1963–74: 53 deaths in hospital. Br Med J 2:721–723
Macdonald JB, Seaton A, Williams DA (1976) Asthma deaths in Cardiff 1963–74: 90 deaths outside the hospital. Br Med J 1:1493
Nadel JA (1984) Inflammation and asthma. J Allergy Clin Immunol 73:651–653
Ogirala RG, Enden JB, Aldrich TK (1989) High-dose intramuscular triamcinolone in life-threatening asthma (abstract). Chest 96:180S
Ogirala RG, et al (1991) High-dose intramuscular triamcinolone in severe, chronic, life-threatening asthma. N Engl J Med 324:585–589
Tunbridge WMG, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 7:481–493
Author information
Authors and Affiliations
Additional information
Offprint requests to: R. G. Ogirala
Rights and permissions
About this article
Cite this article
McGivneyl, S.A., Ogirala, R.G. Effect of high-dose intramuscular triamcinolone in older adults with severe, chronic asthma. Lung 172, 73–78 (1994). https://doi.org/10.1007/BF00185078
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00185078